Scarab Genomics LLC
Madison, WI
- UEI
- S4XQJDL7DN15
- CAGE
- 47GT9
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Partnership or Limited Liability Partnership
- NAICS codes registered in SAM.gov
- SAM.gov registration date
- Physical address
- 1202 Ann St, Madison, WI 53713, USA
- Website
- scarabgenomics.com
- Founded
- 2002
- Employees
- 11-50
- Estimated annual revenue
- $1M-$10M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Development of a continuous microbial fermentation system using reduced genome e. Coli that undergo programmed autolysis… | National Institute of General Medical Sciences | $1,854,656 | |
| An improved low-endotoxin clean genome e. Coli strain for production of biological products - abstract e. Coli has… | National Institute of General Medical Sciences | $1,648,252 | |
| Production of antibody therapeutic fragments by reduced genome e. Coli in continuous culture | National Institute of Allergy and Infectious Diseases | $5,757,012 | |
| Lysis-free extraction of biopharmaceuticals from the periplasm of clean genome e. Coli | National Institute of Allergy and Infectious Diseases | $1,805,310 | |
| Increasing available choices for conjugate vaccine technology by producing carrier proteins in scarab genomics?… | National Institute of Allergy and Infectious Diseases | $1,815,184 |
About Scarab Genomics LLC
Scarab Genomics LLC is a biotechnology company located in Madison, Wisconsin, specializing in advanced genomic and microbial engineering technologies. The company has developed a proprietary "clean genome" E. coli platform, which involves creating reduced genome bacterial strains with enhanced genetic stability and reduced potential for contamination. Registered in the System for Award Management (SAM) since 2005, Scarab Genomics operates as a for-profit corporate entity focused on innovative biotechnological research and development, with a particular emphasis on improving bacterial strain design for biopharmaceutical production.
The company has received federal grant awards from the National Institute of General Medical Sciences (NIGMS), focusing on developing advanced microbial fermentation systems and low-endotoxin E. coli strains for biological product manufacturing. Recent grant projects include developing a continuous microbial fermentation system using reduced genome E. coli that undergoes programmed autolysis, which enables more efficient production and purification of recombinant proteins and plasmid DNA. Scarab Genomics has also been involved in sub-awards with DNAStar, Inc., performing critical work in antibody candidate expression, preparation, and validation. These projects involve complex technical objectives such as optimizing lysis systems, expressing commercially relevant proteins like insulin, reducing endotoxin levels, and enhancing genetic stability for nucleic acid and protein production. The company's grants typically run multiple years, with current projects extending through 2027, and demonstrate a consistent focus on advancing biotechnological manufacturing processes through innovative genomic engineering.
Quick answers
What is Scarab Genomics LLC's UEI?
Scarab Genomics LLC's Unique Entity ID (UEI) in SAM.gov is S4XQJDL7DN15.
What is Scarab Genomics LLC's CAGE code?
Scarab Genomics LLC's CAGE code is 47GT9.
What is Scarab Genomics LLC's primary NAICS code?
Scarab Genomics LLC's primary NAICS code is 541714 (Research and Development in Biotechnology (except Nanobiotechnology)).
Where is Scarab Genomics LLC located?
Scarab Genomics LLC's physical address in SAM.gov is 1202 Ann St, Madison, WI 53713, USA.
Is Scarab Genomics LLC registered in SAM.gov?
Yes. Scarab Genomics LLC's SAM.gov registration is active through March 10, 2027.
What is Scarab Genomics LLC's most recent federal award?
Scarab Genomics LLC's most recent federal grant award is Development of a continuous microbial fermentation system using reduced genome e. Coli that undergo programmed autolysis… (R44GM161364), from National Institute of General Medical Sciences, on September 15, 2025.
On GovTribe
See Scarab Genomics LLC's full federal record
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors